Reasons for switching from a generic to a brand-name drug:: example of allopurinol

被引:0
|
作者
Laroche, M. L.
Crepin, S.
Rolland, G.
Merle, L.
机构
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
103
引用
收藏
页码:22 / 22
页数:1
相关论文
共 50 条
  • [1] Economic Impact of Switchback from Generic to Brand-Name Drugs: Example of Allopurinol
    Laroche, M. L.
    Crepin, S.
    Deysson, M.
    Merle, L.
    [J]. DRUG SAFETY, 2009, 32 (10) : 905 - 905
  • [2] Reasons for Switchback from Generic to Brand-Name Drugs in a Cohort of Patients Treated by Allopurinol
    Laroche, M. L.
    Crepin, S.
    Deysson, M.
    Merle, L.
    [J]. DRUG SAFETY, 2009, 32 (10) : 905 - 906
  • [3] A brand-name generic
    Savage, PR
    [J]. IEEE SPECTRUM, 2004, 41 (10) : 60 - 61
  • [4] Safety of switching from brand-name to generic levetiracetam in patients with epilepsy
    Bosak, Magdalena
    Slowik, Agnieszka
    Turaj, Wojciech
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 : 2287 - 2291
  • [5] Switching from Brand-Name to Generic Psychotropic Medications: A Literature Review
    Desmarais, Julie Eve
    Beauclair, Linda
    Margolese, Howard C.
    [J]. CNS NEUROSCIENCE & THERAPEUTICS, 2011, 17 (06) : 750 - 760
  • [6] Brand-name and generic antiepileptics
    Hussar, Daniel A.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2009, 66 (18) : 1608 - 1608
  • [7] Brand-name versus generic
    Copeland, Kennon R.
    Boccuzzi, Stephen J.
    [J]. HEALTH AFFAIRS, 2007, 26 (04) : 1198 - 1199
  • [8] The effect of inertia on brand-name versus generic drug choices
    Ito, Yuki
    Hara, Konan
    Kobayashi, Yasuki
    [J]. JOURNAL OF ECONOMIC BEHAVIOR & ORGANIZATION, 2020, 172 : 364 - 379
  • [9] Updated trends in US brand-name and generic drug competition
    Grabowski, Henry
    Long, Genia
    Mortimer, Richard
    Boyo, Ani
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2016, 19 (09) : 836 - 844
  • [10] Continuing trends in US brand-name and generic drug competition
    Grabowski, Henry
    Long, Genia
    Mortimer, Richard
    Bilginsoy, Mehmet
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2021, 24 (01) : 908 - 917